Could & Baker Nigeria Plc revealed its full-year 2025 unaudited outcomes, reporting a revenue earlier than tax of N6.55 billion for the yr, a big enchancment from the N2.57 billion recorded in 2024.
For the fourth quarter, the corporate posted a revenue earlier than tax of N1.64 billion, in contrast with a loss earlier than tax of N168.46 million in This fall 2024, reflecting a powerful year-on-year turnaround.
Throughout each the full-year and fourth-quarter efficiency, robust pharmaceutical gross sales, decrease administrative bills, and curiosity revenue supported the corporate’s bottom-line profitability.
This progress was additionally mirrored within the firm’s earnings per share, which rose to N2.58 from N0.93, indicating an enchancment in shareholder returns.
Key Highlights (FY2025 vs FY2024)
- Income: N38.26 billion (up 32.38% YoY from N28.9 billion)
- Gross revenue: N13.14 billion (up 54.4% YoY from N8.51 billion)
- Working revenue: N6.53 billion (up from N2.56 billion)
- Revenue earlier than tax: N6.55 billion (up from N2.57 billion)
- Revenue after tax: N4.45 billion (up from N1.62 billion)
- Whole belongings: N25.61 billion (up from N22.45 billion)
- Retained earnings: N9.3 billion (up from N5.6 billion)
Driving the numbers
Income for the yr hit N38.2 billion, pushed primarily by the pharmaceutical phase, which generated N37.77 billion or 98.72% and accounting for the overwhelming majority of group turnover.
- The beverage phase contributed N489.45 million to whole income, remaining a comparatively small however steadily rising a part of the enterprise.
- After accounting for a value of gross sales of N25.1 billion, gross revenue stood at N13.1 billion, up 54.43% yr on yr.
- The corporate recorded different losses of N29.6 million and promoting and advertising and marketing bills of N3.9 billion however managed to trim administrative bills to N2.6 billion, down from N2.8 billion.
Consequently, working revenue greater than doubled to N6.5 billion, up from N2.5 billion, reflecting wholesome operational effectivity.
- Finance prices elevated to N673.13 million from N370.11 million, however this was partly offset by a pointy rise in curiosity revenue to N711.57 million from N407.49 million, supported by greater bank curiosity.
- Consequently, pre-tax revenue rose to N6.5 billion, up from N2.5 billion in 2024.
- On the stability sheet, whole belongings expanded to N25.6 billion from N22.4 billion. Money and money equivalents of N6.5 billion and property, plant, and tools of N6.3 billion have been the biggest contributors.
Whole fairness additionally swelled to N13.6 billion from N9.8 billion, with retained earnings of N9.3 billion making up the majority of the rise.
On the liabilities aspect, whole obligations declined to N11.9 billion from N12.5 billion, as borrowings narrowed to N3.3 billion from N3.5 billion.
Market response
Could & Baker Nigeria Plc’s shares are presently priced at N43.45, delivering a month-to-date return of 24.14% in February 2026.
12 months-to-date, the inventory has surged 128.68%, doubtless pushed by constructive sentiment within the pharmaceutical sector and optimism across the firm’s robust monetary efficiency.
